A 45-year-old Burmese man presented with a translator for his first eye examination. His chief complaint was blurry vision at night. His systemic health history was significant for HIV diagnosed 1 year ago, for which he was on Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate, Bristol-Myers Squibb and Gilead Sciences). He was not sure of his CD4 count or viral load. The patient was born and raised in Burma (now Myanmar), in Southeast Asia. He had moved to the U.S. about 1 year ago.